MGP
PFE icon

M&G plc’s Pfizer PFE Stock Holding History

M&G plc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10M Sell
418,626
-128,047
-23% -$3.35M 0.05% 219
2026
Q1 		$15.3M Sell
546,673
-30,507
-5% -$812K 0.08% 151
2025
Q4 		$14.4M Buy
577,180
+30,696
+6% +$774K 0.07% 160
2025
Q3 		$13.7M Sell
546,484
-83,970
-13% -$2.07M 0.07% 159
2025
Q2 		$15.1M Sell
630,454
-99,650
-14% -$2.32M 0.08% 152
2025
Q1 		$18.3M Sell
730,104
-66,449
-8% -$1.74M 0.09% 144
2024
Q4 		$21.5M Sell
796,553
-1,891
-0.2% -$51.3K 0.13% 137
2024
Q3 		$23.2M Sell
798,444
-14,979
-2% -$437K 0.08% 136
2024
Q2 		$22.8M Buy
813,423
+103,254
+15% +$2.84M 0.09% 129
2024
Q1 		$19.9M Buy
+710,169
New +$19.7M 0.08% 129

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

M&G plc's PFE Position: Q2 2026 in Review

M&G plc reduced its Pfizer (PFE) stake by 23% in Q2 2026, selling an estimated $3.35M and leaving 418,626 shares worth $10M. The position accounts for 0.05% of the portfolio, ranked #219.

M&G plc first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. The position peaked at $23.2M in Q3 2024. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • M&G plc held 418,626 shares of Pfizer worth $10M as of Q2 2026.
  • M&G plc sold 128,047 Pfizer shares in Q2 2026, an estimated $3.35M.
  • Pfizer made up 0.05% of M&G plc's portfolio in Q2 2026, its #219 holding.
  • M&G plc first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
  • M&G plc's Pfizer position peaked at $23.2M in Q3 2024.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.